104 related articles for article (PubMed ID: 1711629)
1. Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin-II and to regional conversion rates of angiotensin-I: a pilot study in humans.
Gasic S; Kleinbloesem CH; Heinz G; Waldhäusl W
J Cardiovasc Pharmacol; 1991 Apr; 17(4):615-20. PubMed ID: 1711629
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evidence of peripheral conversion of angiotensin within the human leg: effects of local angiotensin-I administration and angiotensin-converting enzyme inhibition on regional blood flow and angiotensin-II balance across the leg.
Gasic S; Heinz G; Kleinbloesem C
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):436-40. PubMed ID: 2147739
[TBL] [Abstract][Full Text] [Related]
3. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
Gasic S; Heinz G; Kleinbloesem C; Korn A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 does not mediate angiotensin II-dependent nonischemic peripheral vasoconstriction in healthy men: a pilot study.
Gasic S; Eichler HG; Kyrle PA; Wolzt M; Eidenberger T; Vierhapper H
Int J Clin Pharmacol Ther; 1997 Feb; 35(2):56-60. PubMed ID: 9147708
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
Ekelund U
Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition has no effect on blood pressure and splanchnic perfusion after cardiac surgery.
Parviainen I; Rantala A; Ruokonen E; Tenhunen J; Takala J
J Crit Care; 1998 Jun; 13(2):73-80. PubMed ID: 9627274
[TBL] [Abstract][Full Text] [Related]
7. Splanchnic blood flow and hepatic glucose production in exercising humans: role of renin-angiotensin system.
Bergeron R; Kjaer M; Simonsen L; Bülow J; Skovgaard D; Howlett K; Galbo H
Am J Physiol Regul Integr Comp Physiol; 2001 Dec; 281(6):R1854-61. PubMed ID: 11705770
[TBL] [Abstract][Full Text] [Related]
8. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition.
Nishiyama A; Seth DM; Navar LG
J Am Soc Nephrol; 2002 Sep; 13(9):2207-12. PubMed ID: 12191964
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.
Symons JD; Stebbins CL
J Cardiovasc Pharmacol; 1996 Aug; 28(2):223-31. PubMed ID: 8856477
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin blockade on the splanchnic circulation in normotensive humans.
Stadeager C; Hesse B; Henriksen O; Christensen NJ; Bonde-Petersen F; Mehlsen J; Giese J
J Appl Physiol (1985); 1989 Aug; 67(2):786-91. PubMed ID: 2551874
[TBL] [Abstract][Full Text] [Related]
11. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
[TBL] [Abstract][Full Text] [Related]
12. The urinary bladder angiotensin system: response to infusions of angiotensin I and angiotensin-converting enzyme inhibitors.
Weaver-Osterholtz D; Reams G; Wu Z; Knaus J; Campbell F; Bauer JH
Am J Kidney Dis; 1996 Oct; 28(4):603-9. PubMed ID: 8840953
[TBL] [Abstract][Full Text] [Related]
13. The bladder angiotensin system in female rats: response to infusions of angiotensin I and the angiotensin converting enzyme inhibitor enalaprilat.
Weaver-Osterholtz D; Reams G; De Vergel CF; Bauer JH
J Urol; 2001 May; 165(5):1735-8. PubMed ID: 11342966
[TBL] [Abstract][Full Text] [Related]
14. Systemic and regional hemodynamic effects of enalaprilat infusion in experimental normotensive sepsis.
Rahal L; Garrido AG; Cruz RJ; Rocha e Silva M; Poli-de-Figueiredo LF
Braz J Med Biol Res; 2006 Sep; 39(9):1205-15. PubMed ID: 16981048
[TBL] [Abstract][Full Text] [Related]
15. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.
Benjamin N; Cockcroft JR; Collier JG; Dollery CT; Ritter JM; Webb DJ
J Physiol; 1989 May; 412():543-55. PubMed ID: 2557432
[TBL] [Abstract][Full Text] [Related]
16. Continuous i.v. administration of the angiotensin-converting enzyme inhibitor enalaprilat in the critically ill: effects on regulators of circulatory homeostasis.
Boldt J; Menges T; Wollbrück M; Härter K; Hempelmann G
J Cardiovasc Pharmacol; 1995 Mar; 25(3):416-23. PubMed ID: 7769807
[TBL] [Abstract][Full Text] [Related]
17. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
Hollenberg NK; Fisher ND; Price DA; Williams GH
Am J Hypertens; 2000 May; 13(5 Pt 1):498-503. PubMed ID: 10826400
[TBL] [Abstract][Full Text] [Related]
18. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats.
Fox J; Guan S; Hymel AA; Navar LG
Am J Physiol; 1992 May; 262(5 Pt 2):F902-9. PubMed ID: 1317125
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
Petrie MC; Padmanabhan N; McDonald JE; Hillier C; Connell JM; McMurray JJ
J Am Coll Cardiol; 2001 Mar; 37(4):1056-61. PubMed ID: 11263608
[TBL] [Abstract][Full Text] [Related]
20. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ
Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
